Trifluoroacetic acid → HCID 86622809, compound
Reaction equation
COC1C=CC(C([NH:18][C:19]2[N:27]=[C:26]([Cl:28])[N:25]=[C:24]3[C:20]=2[N:21]=[CH:22][N:23]3[C@@H:29]2[CH2:33][C@H:32]([N:34]3[CH:38]=[C:37]([CH3:39])[CH:36]=[N:35]3)[C@@H:31]([OH:40])[C@H:30]2[OH:41])C2C=CC(OC)=CC=2)=CC=1.[C:42]([OH:48])([C:44]([F:47])([F:46])[F:45])=[O:43]>>[F:45][C:44]([F:47])([F:46])[C:42]([OH:48])=[O:43].[NH2:18][C:19]1[N:27]=[C:26]([Cl:28])[N:25]=[C:24]2[C:20]=1[N:21]=[CH:22][N:23]2[C@@H:29]1[CH2:33][C@H:32]([N:34]2[CH:38]=[C:37]([CH3:39])[CH:36]=[N:35]2)[C@@H:31]([OH:40])[C@H:30]1[OH:41]Participants
3
Procedure
(1R,2S,3R,5S)-3-(6-{[Bis-(4-methoxy-phenyl)-methyl]-amino}-2-chloro-purin-9-yl)-5-(4-methyl-pyrazol-1-yl)-cyclopentane-1,2-diol (Intermediate BB1) (0.020 g, 35 μmol) is dissolved in TFA (200 μL). The reaction mixture is stirred at room temperature. The reaction is shown to be complete by LCMS after 2 hours. The solvent is removed in vacuo and the title compound is obtained after purification by reverse phase column chromatography (Isolute™ C18, 0-100% acetonitrile in water—0.1% TFA). 1H nmr (MeOD, 400 MHz); 8.50 (s, 1H), 7.85 (s, 1H), 7.55 (s, 1H), 4.95 (m, 1H), 4.70 (m, 1H), 4.65 (m, 1H), 4.30 (m, 1H), 2.95 (m, 1H), 2.65 (m, 1H), 2.15 (s, 3H), MS (ES+) m/e 350 (MH+).
Workup
- customThe solvent is removed in vacuo
Sources & evidence
- ORD record
- ord-798df6a2b9cf4735a7a88a7ea737dcf5
- Source dataset
- uspto-grants-2012_02
- Patent number
- US08114877B2
Reaction notes
Loading…